Other vaccines

  • One-pager value communication tool for the measles, mumps and rubella (MMR) vaccine
  • Development of an e-v@luate EVIDENCE platform for a vaccines portfolio
  • Payer material development for vaccines in hepatitis A, rotavirus gastroenteritis (RVGE), shingles and varicella
  • Payer value slides for a varicella vaccine
  • Payer value deck for an MMR and varicella vaccine
  • Payer communications on a herpes zoster vaccine
  • e-v@luate platform on vaccines for HPV, varicella, MMR, shingles, hepatitis A and rotavirus
  • Payer slide deck to support HE models in dengue fever
  • Payer value deck update for a rotavirus vaccine
  • Estimating the return on investment from investing in adult immunisation in Europe
  • Strategic consultancy on physician attitudes and preferences regarding adult vaccinations
  • Payer value deck in adult rotavirus gastroenteritis
  • Payer value deck on the humanistic burden of rotavirus
  • Manuscript, economic model and literature review on the burden of rotavirus and the impact of vaccination on health care utilization in Europe
  • Value communications support and manuscript on parental attitudes and knowledge of the varicella vaccination in Sweden
  • Global value dossier on dengue fever
  • Structured literature review and value strategic insight to understand the prevalence and burden of vaccine-preventable diseases (haemophilus influenzae, hepatitis A & B, HPV-associated cancers, influenza, measles, mumps, rubella, meningococcal disease, pneumonia, tetanus, diphtheria, whooping cough, chicken pox, and shingles) amongst sub-populations identified in the ACIP recommendations
  • Clinical outcome assessment (COA) landscape review and literature review in a vaccine for respiratory bacterial infections

Related categories

Experience,  Special interest,  Vaccines